查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2084912

過敏診斷市場：2026-2032年全球市場預測（依測試類型、技術、檢體類型、過敏原類型和最終用戶分類）

Allergy Diagnostics Market by Test Type, Technology, Sample Type, Allergen Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，過敏診斷市場將成長至 98.6 億美元，複合年成長率為 6.61%。

主要市場統計數據
基準年 2025 63億美元
預計年份：2026年 66.7億美元
預測年份 2032 98.6億美元
複合年成長率 (%) 6.61%

過敏診斷市場執行摘要

隨著過敏性鼻炎、氣喘、食物過敏、異位性皮膚炎、藥物過敏和昆蟲毒液過敏在全球範圍內持續增加，過敏診斷市場正成為精準醫療的核心支柱。根據世界過敏組織（WAO）估計，全球約有10%至40%的人口受到過敏性疾病的影響；而世界衛生組織（WHO）估計，2019年全球有2.62億人患有氣喘，這凸顯了對精準過敏檢測和長期疾病管理的持續需求。

過敏診斷的變革性變化

過敏診斷領域正經歷三大變革：從以萃取物為基礎的檢測方法轉變為分子過敏診斷的轉變、自動化免疫檢測平台的擴展，以及臨床上對檢測結果日益成長的期望——這些結果不僅要能確認致敏情況，還要有助於制定治療策略。成分解析度診斷對於區分真正的食物過敏風險和交叉反應尤其重要，有助於減少不必要的食物排除飲食，並改善過敏原免疫療法的選擇。

人工智慧（AI）的累積影響

人工智慧 (AI) 正透過模式識別、臨床風險分層、檢查室工作流程最佳化以及輔助解讀多參數 IgE 檢測結果，逐步影響過敏診斷。 AI 工具能夠幫助臨床醫生關聯症狀、接觸史、總 IgE、特異性IgE、嗜酸性粒細胞計數、肺功能檢查和合併症數據，從而提高診斷信心，尤其是在專科醫生資源有限的情況下。

過敏診斷的關鍵區域見解

亞太地區是過敏診斷領域最具活力的地區之一，這主要得益於都市化、空氣污染加劇、中產階級醫療費用支出不斷成長，以及中國、印度、日本、韓國和澳洲等國檢測基礎設施的不斷完善。北美地區仍然是高價值地區，這得益於其較高的臨床意識、完善的保險報銷體系、規範的診斷技術創新，以及美國疾病管制與預防中心（CDC）報告的兒童和成人過敏負擔（包括季節性過敏和食物過敏）。

主要經濟領域的關鍵群體洞察

在東協市場，隨著都市區成長和私人診斷機構的擴張，過敏檢測的可近性正在提高，其重要性也日益凸顯，但成本效益和專家的可及性仍存在差異。在海灣合作理事會國家，對先進醫院系統和檢查室自動化的投資不斷增加，從而催生了對高通量免疫檢測平台和適用於室內過敏原、塵蟎、黴菌和環境過敏原分析的過敏原檢測組合的需求。

主要國家過敏診斷趨勢

美國憑藉其先進的檢查室網路、廣泛應用血清特異性IgE檢測以及積極推行專業過敏治療，引領過敏診斷領域的創新。加拿大則強調以指南為基礎的醫療實踐，並透過其省級醫療保健系統確保醫療服務的公平獲取。墨西哥和巴西的私人實驗室和呼吸道過敏管理需求日益成長，其中巴西在拉丁美洲的影響力尤其顯著。英國、德國、法國、義大利和西班牙則受益於成熟的醫療保健體系、在歐洲過敏研究領域的領先地位以及基於成分的診斷方法的不斷普及。

為行業領導者提供的實用建議

產業領導者應優先考慮符合世界過敏組織（WAO）、歐洲過敏與臨床免疫學會（EAACI）、美國過敏與免疫學會（AAAI）以及國家過敏指南的、經臨床檢驗的檢測項目。投資應集中於分子過敏診斷、自動化免疫檢測、適用兒童的檢體採集方法以及能夠減少假陽性結果並支持更好臨床決策的數位化診斷工具。

調查方法

本執行摘要基於二手研究，參考了經核實的公共衛生、監管和臨床資料，包括世界衛生組織 (WHO)、世界過敏組織 (WAO)、美國疾病管制與感染疾病中心 (CDC)、美國國立衛生研究院/國家過敏症和傳染病研究所 (NIH/NIAID)、歐洲食品藥物管理局(EAACI)、美國美國藥物學、美國氣喘管理局 (IEMA)以及同儕檢驗的過敏和免疫學資訊來源。本分析重點在於流行病學、診斷途徑、技術應用、保險報銷框架和當地醫療保健基礎設施。

結論

過敏診斷正從過敏治療中的輔助角色轉變為實現精準醫療、預防醫學和標靶治療的策略要素。全球過敏盛行率的上升、人們對食物和呼吸道過敏的認知不斷提高，以及免疫檢測和分子檢測的普及，都對準確且具有臨床實用價值的檢測方法產生了持續的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 過敏診斷市場：依檢測類型分類

  • 皮內試驗
  • 斑貼試驗
  • 血清特異性IgE檢測
    • 化學冷光免疫檢測
    • 酵素免疫分析法（ELISA）
    • 放射性過敏原檢測
  • 皮膚點刺試驗

第8章：過敏診斷市場：依技術分類

  • 化學冷光免疫檢測
  • 酵素免疫分析法
  • 螢光酵素免疫分析法
  • 放射性過敏原檢測

第9章：過敏診斷市場：依樣本類型分類

  • 血
  • 皮膚
  • 唾液
  • 鼻腔液

第10章 過敏診斷市場：依過敏原類型分類

  • 接觸性過敏原
  • 藥物過敏原
  • 食物過敏原
  • 吸入性過敏原

第11章 過敏診斷市場：依最終用戶分類

  • 門診部
  • 診斷檢查室
  • 醫院和診所

第12章 過敏診斷市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 過敏診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 過敏診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • ALK-Abello A/S
  • Allergy Therapeutics PLC
  • Astra Biotech GmbH
  • Bausch & Lomb Incorporated
  • Biomerieux SA
  • Danaher Corporation
  • Dr. Fooke-Achterrath Laboratorien GmbH
  • DST Diagnostische Systeme & Technologien GmbH
  • Erba Group
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • HAL Allergy BV
  • Hitachi, Ltd.
  • HOB Biotech Group Corp., Ltd.
  • HollisterStier by Jubilant Life Sciences Limited
  • HYCOR Biomedical
  • Lincoln Diagnostics, Inc.
  • Minaris Medical America, Inc.
  • Neogen Corporation
  • Omega Diagnostics Group PLC
  • Parkway Pantai Ltd.
  • Quest Diagnostics Incorporated
  • R-Biopharm AG
  • Romer Labs Division Holding GmbH by Royal DSM
  • Siemens AG
  • Stallergenes Greer International AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-436901065A32

The Allergy Diagnostics Market is projected to grow by USD 9.86 billion at a CAGR of 6.61% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.30 billion
Estimated Year [2026] USD 6.67 billion
Forecast Year [2032] USD 9.86 billion
CAGR (%) 6.61%

Allergy Diagnostics Executive Summary

The allergy diagnostics market is becoming a core pillar of precision medicine as allergic rhinitis, asthma, food allergy, atopic dermatitis, drug allergy, and insect venom hypersensitivity continue to rise worldwide. The World Allergy Organization reports that allergic diseases affect an estimated 10% to 40% of the global population, while the World Health Organization estimated 262 million people lived with asthma in 2019, underscoring sustained demand for accurate allergy testing and long-term disease management.

Clinical adoption is shifting from broad symptom-based assessment toward evidence-based diagnosis using skin prick testing, serum-specific IgE testing, component-resolved diagnostics, multiplex immunoassays, and digital decision support. For manufacturers, laboratories, health systems, and payers, growth is tied to faster turnaround times, validated biomarkers, guideline-aligned testing, and improved access across high-burden pediatric and adult populations.

Transformative Shifts in Allergy Diagnostics

The allergy diagnostics landscape is being reshaped by three major shifts: the move from extract-based testing to molecular allergy diagnostics, the expansion of automated immunoassay platforms, and the growing clinical expectation for test results that guide treatment decisions rather than simply confirm sensitization. Component-resolved diagnostics are especially important for differentiating genuine food allergy risk from cross-reactivity, which can help reduce unnecessary avoidance diets and improve allergen immunotherapy selection.

A second transformation is occurring in care delivery. Allergy testing is expanding beyond specialist clinics into hospital laboratories, primary care networks, retail-linked diagnostics, and telehealth-supported pathways. This trend is supported by increasing awareness of asthma-allergy comorbidity, food allergy safety, and the need for early diagnosis in children, but it also raises the bar for quality control, clinician education, and reimbursement clarity.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence allergy diagnostics through pattern recognition, clinical risk stratification, laboratory workflow optimization, and interpretation support for multiplex IgE panels. AI-enabled tools can help clinicians connect symptoms, exposure history, total IgE, specific IgE, eosinophil counts, spirometry, and comorbidity data to improve diagnostic confidence, particularly where specialist access is limited.

The cumulative impact of AI will depend on validation, explainability, and regulatory oversight. Industry leaders should prioritize clinically governed AI that improves sensitivity, specificity, and turnaround time without overdiagnosis. The strongest opportunities are expected in triage algorithms, automated assay quality monitoring, population-level allergy surveillance, and decision support for immunotherapy eligibility.

Key Regional Insights for Allergy Diagnostics

Asia-Pacific is one of the most dynamic regions for allergy diagnostics, supported by urbanization, air pollution exposure, rising middle-class healthcare spending, and expanding laboratory infrastructure in China, India, Japan, South Korea, and Australia. North America remains a high-value region driven by strong clinical awareness, established reimbursement pathways, regulated diagnostic innovation, and the documented allergy burden reported by the CDC, including seasonal and food allergies in children and adults.

Europe benefits from guideline-driven care, extensive specialist networks, and active research communities, particularly in Germany, France, Italy, Spain, and the United Kingdom. Latin America is advancing through private laboratory networks and growing asthma and rhinitis management programs, while the Middle East is seeing demand linked to dust exposure, indoor allergens, and investment in tertiary care. Africa remains underpenetrated, with progress dependent on affordable testing, workforce training, and integration with respiratory disease programs.

Key Group Insights Across Major Economic Blocs

ASEAN markets are gaining relevance as expanding urban populations and private diagnostic chains increase access to allergy testing, although affordability and specialist availability remain uneven. GCC countries are investing in advanced hospital systems and laboratory automation, creating demand for high-throughput immunoassay platforms and allergy panels suited to indoor, dust mite, mold, and environmental allergen profiles.

The European Union is defined by harmonized regulatory expectations, strong evidence standards, and growing adoption of molecular diagnostics. BRICS countries represent scale-driven opportunity, with China, India, and Brazil expanding diagnostic capacity while Russia and South Africa face access and infrastructure variability. G7 markets continue to lead in innovation, reimbursement sophistication, and clinical guideline adoption, while NATO member countries collectively emphasize resilient healthcare supply chains and standardized laboratory quality systems.

Key Country Insights in Allergy Diagnostics

The United States leads in allergy diagnostics innovation through advanced laboratory networks, broad use of serum-specific IgE testing, and strong adoption of specialty allergy care, while Canada emphasizes guideline-based care and equitable access through provincial systems. Mexico and Brazil show rising demand through private laboratories and respiratory allergy management, with Brazil offering notable scale in Latin America. The United Kingdom, Germany, France, Italy, and Spain benefit from mature healthcare systems, European allergy research leadership, and growing use of component-resolved diagnostics.

Russia presents a mixed environment shaped by centralized healthcare capacity and regional access gaps. China and India are high-growth markets due to large patient populations, urban air quality concerns, and expanding diagnostic infrastructure, while Japan and South Korea are advanced markets with strong technology adoption and high-quality laboratory standards. Australia demonstrates sophisticated allergy and immunology practice, particularly in food allergy research, pediatric allergy care, and evidence-based testing pathways.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated test menus that align with WAO, EAACI, AAAAI, and national allergy guidelines. Investment should focus on molecular allergy diagnostics, automated immunoassays, pediatric-friendly sampling, and digital interpretation tools that reduce false positives and support better clinical decisions.

Commercial teams should build region-specific access strategies, including reimbursement evidence in mature regions and affordability models in emerging regions. Partnerships with hospitals, reference laboratories, asthma programs, and primary care networks can expand testing adoption, while education for clinicians and patients can reduce misdiagnosis and inappropriate allergen avoidance.

Research Methodology

This executive summary is based on secondary research from verified public-health, regulatory, and clinical sources, including the World Health Organization, World Allergy Organization, CDC, NIH/NIAID, EAACI, AAAAI, FDA, EMA, and peer-reviewed allergy and immunology literature. The analysis emphasizes epidemiology, diagnostic pathways, technology adoption, reimbursement context, and regional healthcare infrastructure.

A structured triangulation approach compares disease-burden indicators, regulatory developments, laboratory adoption patterns, industry activity, and clinical guideline trends. Insights are reviewed for consistency, relevance, and applicability to support executive decision-making in allergy diagnostics.

Conclusion

Allergy diagnostics is moving from a supporting role in allergy care to a strategic enabler of precision medicine, preventive health, and targeted therapy. Rising global allergy prevalence, improved awareness of food and respiratory allergies, and expanding access to immunoassay and molecular testing are creating durable demand for accurate and clinically useful testing.

The next phase of leadership will belong to organizations that combine analytical accuracy, clinical utility, automation, AI-enabled interpretation, and equitable access. Providers that deliver reliable, guideline-aligned, and regionally relevant allergy testing solutions will be best positioned for long-term growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Allergy Diagnostics Market, by Test Type

  • 7.1. Intradermal Test
  • 7.2. Patch Test
  • 7.3. Serum-Specific IgE Test
    • 7.3.1. Chemiluminescence Immunoassay
    • 7.3.2. Enzyme-Linked Immunosorbent Assay
    • 7.3.3. Radioallergosorbent Test
  • 7.4. Skin Prick Test

8. Allergy Diagnostics Market, by Technology

  • 8.1. Chemiluminescence Immunoassay
  • 8.2. Enzyme-Linked Immunosorbent Assay
  • 8.3. Fluorescent Enzyme Immunoassay
  • 8.4. Radioallergosorbent Test

9. Allergy Diagnostics Market, by Sample Type

  • 9.1. Blood
  • 9.2. Skin
  • 9.3. Saliva
  • 9.4. Nasal Fluids

10. Allergy Diagnostics Market, by Allergen Type

  • 10.1. Contact Allergen
  • 10.2. Drug Allergen
  • 10.3. Food Allergen
  • 10.4. Inhalant Allergen

11. Allergy Diagnostics Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals & Clinics

12. Allergy Diagnostics Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Allergy Diagnostics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Allergy Diagnostics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. ALK-Abello A/S
  • 16.3. Allergy Therapeutics PLC
  • 16.4. Astra Biotech GmbH
  • 16.5. Bausch & Lomb Incorporated
  • 16.6. Biomerieux SA
  • 16.7. Danaher Corporation
  • 16.8. Dr. Fooke-Achterrath Laboratorien GmbH
  • 16.9. DST Diagnostische Systeme & Technologien GmbH
  • 16.10. Erba Group
  • 16.11. Eurofins Scientific
  • 16.12. F. Hoffmann-La Roche Ltd
  • 16.13. HAL Allergy B.V.
  • 16.14. Hitachi, Ltd.
  • 16.15. HOB Biotech Group Corp., Ltd.
  • 16.16. HollisterStier by Jubilant Life Sciences Limited
  • 16.17. HYCOR Biomedical
  • 16.18. Lincoln Diagnostics, Inc.
  • 16.19. Minaris Medical America, Inc.
  • 16.20. Neogen Corporation
  • 16.21. Omega Diagnostics Group PLC
  • 16.22. Parkway Pantai Ltd.
  • 16.23. Quest Diagnostics Incorporated
  • 16.24. R-Biopharm AG
  • 16.25. Romer Labs Division Holding GmbH by Royal DSM
  • 16.26. Siemens AG
  • 16.27. Stallergenes Greer International AG
  • 16.28. Tecan Trading AG
  • 16.29. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ALLERGY DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ALLERGY DIAGNOSTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ALLERGY DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ALLERGY DIAGNOSTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ALLERGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ALLERGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRADERMAL TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRADERMAL TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRADERMAL TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PATCH TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PATCH TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PATCH TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SERUM-SPECIFIC IGE TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SERUM-SPECIFIC IGE TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SERUM-SPECIFIC IGE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SKIN PRICK TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SKIN PRICK TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SKIN PRICK TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLUORESCENT ENZYME IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLUORESCENT ENZYME IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLUORESCENT ENZYME IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SKIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SKIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SKIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NASAL FLUIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NASAL FLUIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NASAL FLUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONTACT ALLERGEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONTACT ALLERGEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONTACT ALLERGEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DRUG ALLERGEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DRUG ALLERGEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DRUG ALLERGEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FOOD ALLERGEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FOOD ALLERGEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FOOD ALLERGEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INHALANT ALLERGEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INHALANT ALLERGEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INHALANT ALLERGEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GCC ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 127. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. G7 ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 148. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. NATO ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 155. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 170. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 177. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 184. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 198. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 205. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 212. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 219. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 226. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 240. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 247. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 254. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2018-2032 (USD MILLION)
  • TABLE 261. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)